ArticleCureus2024

Effects of Switching From Another Sodium-Glucose Cotransporter 2 Inhibitor to Tofogliflozin on Nocturia in Patients With Type 2 Diabetes.

Saori Inoue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.